Interestingly, ABCG2 is epigenetically regulated by miR-222 in tongue squamous cell carcinoma, and deregulation of the miR-222–ABCG2 contributes to cisplatin resistance, and cancer aggressiveness [169]. This evidence concerns the gene ABCG2 and cancer.